Biomark Diagnostics Overview
- Founded
- 2007
- Status
- Public
- Stock Symbol
- BUX
- Share Price
- $0.10
- (As of Friday Closing)
Biomark Diagnostics General Information
Description
Biomark Diagnostics Inc is a Canada based oncology-focused company. It is engaged in the development of advanced-stage cancer diagnostic business. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection.
Contact Information
Website
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Stock Exchange
CNQ
Primary Office
- 165 - 10551 Shellbridge Way
- Richmond, British Columbia V6X 2W8
- Canada
+1 (604) 000-0000
Biomark Diagnostics Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.10 | $0.10 | $0.05 - $0.22 | $8.45M | 72.9M | 46.9K | -$0.02 |
Biomark Diagnostics Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2020 | FY 2020 31-Mar-2020 | FY 2019 31-Mar-2019 | FY 2018 31-Mar-2018 |
|---|---|---|---|---|
| EV | 7,387 | 8,623 | 3,099 | 3,313 |
| Revenue | 196 | 198 | 0 | 0 |
| EBITDA | (909) | (905) | (416) | (566) |
| Net Income | (911) | (914) | (416) | (566) |
| Total Assets | 390 | 449 | 26 | 40 |
| Total Debt | 4 | 6 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Biomark Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Biomark Diagnostics‘s full profile, request access.
Request a free trial